You can buy or sell PAND and other stocks, options, and ETFs commission-free!
Pandion Therapeutics Inc. Common Stock, also called Pandion Therapeutics, is clinical stage biopharmaceutical company developing novel therapeutics designed to address the unmet needs of patients suffering from autoimmune diseases. The firm develops Therapeutic Autoimmune reguLatOry protein (TALON) drug design and discovery platform. TALON platform employ a modular approach to create a pipeline of product candidates using immunomodulatory effector modules that act at known control nodes within the immune network. The company was founded on December 31, 2018 and is headquartered in Watertown, MA. The listed name for PAND is Pandion Therapeutics Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Mar 31, After Hours